We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
-13.35%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$340B
AUM Growth
-$60.4B
Cap. Flow
-$1.31B
Cap. Flow %
-0.39%
Top 10 Hldgs %
20.28%
Holding
8,274
New
398
Increased
2,517
Reduced
3,856
Closed
651

Sector Composition

Rank Sector Weight
1 Financials 20.3%
2 Technology 11.83%
3 Healthcare 8.85%
4 Energy 7.86%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEEZ
7626
DELISTED
Expand Energy Corp Class B Warrants
EXEEZ
-2,360
Closed -$140K
CLYM
7627
Climb Bio
CLYM
$854M
$0 ﹤0.01%
28
-342
-92% -$1.62K
OKUR
7628
OnKure Therapeutics
OKUR
$158M
$0 ﹤0.01%
2
-51
-96% -$1.19K
NESRW
7629
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$0 ﹤0.01%
2,000
IRD
7630
Opus Genetics
IRD
$310M
$0 ﹤0.01%
5
GRCE
7631
Grace Therapeutics
GRCE
$43.8M
$0 ﹤0.01%
66
+28
+74% +$170
SUNE
7632
SUNation Energy
SUNE
$10.6M
0
-$1K
MTVA
7633
MetaVia Inc
MTVA
$7.59M
0
ABXB
7634
Abacus Flexible Bond Leaders ETF
ABXB
$1.92M
-258
Closed -$6K
PVLA
7635
Palvella Therapeutics
PVLA
$2.24B
$0 ﹤0.01%
+1
New +$182
XYZ
7636
CALL
Block Inc
XYZ
$50.2B
-79,000
Closed -$10.7M
FNGA
7637
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
-30
Closed -$7K
NAGE
7638
Niagen Bioscience
NAGE
$241M
-2,880
Closed -$7K
SPRB
7639
Spruce Biosciences
SPRB
$143M
$0 ﹤0.01%
2
-6
-75% -$769
GDSTW
7640
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$0 ﹤0.01%
+100
New +$9
SYRS
7641
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
53
-301
-85% -$2.82K
ATXI
7642
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
0
PWUPU
7643
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
-25,000
Closed -$252K
CTV
7644
DELISTED
Innovid Corp.
CTV
$0 ﹤0.01%
126
-867
-87% -$3.73K
VIRX
7645
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-2,227
Closed -$11K
VINC
7646
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-50
Closed -$4K
PLMJU
7647
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
-81,345
Closed -$796K
USAP
7648
DELISTED
Universal Stainless & Alloy
USAP
-38
Closed
PPYAU
7649
DELISTED
Papaya Growth Opportunity Corp. I Unit
PPYAU
-15,004
Closed -$150K
LFLYW
7650
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$0 ﹤0.01%
+125
New +$162

Similar funds

Royal Bank of Canada's Q2 2022 Portfolio in Review

As of Q2 2022, Royal Bank of Canada held 8,274 positions worth $340B, down 15% from $400B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada's Q2 2022 filing shows 398 new, 2,517 increased, 3,856 reduced and 651 closed positions. Its largest new stake was Aspen Technology Inc: 92,306 shares worth $17M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $558M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q2 2022 buy was Aspen Technology Inc: 92,306 shares worth $17M.
  • Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $866M increase.
  • Royal Bank of Canada's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $558M.
  • Royal Bank of Canada fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $45.7M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $340B portfolio in Q2 2022.
  • Royal Bank of Canada opened 398 new positions and closed 651 in Q2 2022.
  • Royal Bank of Canada's portfolio value fell 15% quarter-over-quarter to $340B.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.